Wird geladen...
Advances in the treatment of soft tissue sarcoma: focus on eribulin
Eribulin mesylate is a synthetic derivative of halichondrin B isolated from a marine sponge. Its mechanism of action is through microtubule inhibition, which is different from that of taxanes. Eribulin has been approved for the treatment of metastatic breast cancer and more recently for non-operable...
Gespeichert in:
| Veröffentlicht in: | Cancer Manag Res |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798537/ https://ncbi.nlm.nih.gov/pubmed/29440930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S143019 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|